Macrophages enhance cisplatin resistance in gastric cancer through the transfer of circTEX2

Abstract

AbstractCisplatin‐based chemotherapy is often used in advanced gastric cancer (GC) treatment, yet resistance to cisplatin may lead to treatment failure. Mechanisms underlying cisplatin resistance remain unclear. Recent evidence highlighted the role of macrophages in cancer chemoresistance. Macrophage‐derived exosomes were shown to facilitate intercellular communication. Here, we investigated the cisplatin resistance mechanism based on macrophage‐derived exosomes in gastric cancer. Cell growth and apoptosis detection experiments revealed that M2‐polarized macrophages increased the resistance of GC cells to cisplatin. qRT‐PCR, RNAase R assay, actinomycin D assay and cell nucleo‐cytoplasmic separation experiments confirmed the existence of circTEX2 in macrophage cytoplasm, with a higher expression level in M2 macrophages than that in M1 macrophages. Further experiments showed that circTEX2 acted as microRNA sponges for miR‐145 and regulated the expression of ATP Binding Cassette Subfamily C Member 1 (ABCC1). Inhibition of the circTEX2/miR‐145/ABCC1 axis blocked the cisplatin resistance of gastric cancer induced by M2 macrophages, as evidenced by in vitro and in vivo experiments. In conclusion, our research suggests that the exosomal transfer of M2 macrophage‐derived circTEX2 enhances cisplatin resistance in gastric cancer through miR‐145/ABCC1. Additionally, communication between macrophages and cancer cells via exosomes may be a promising therapeutic target for the treatment of cisplatin‐resistant gastric cancer.